HSP 65 Antibodies

Santa Cruz Biotechnology offers a broad range of HSP 65 monoclonal antibodies for investigating heat shock protein 65 in cellular stress responses. HSP 65 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Heat shock protein 65 (HSP 65) functions as a molecular chaperone, assisting in protein folding and protecting cells from stress-induced damage. HSP 65 maintains cellular homeostasis through its protective mechanisms and participates in immune system regulation. Research focusing on HSP 65 has revealed its significance in neurodegenerative disorders and cancer development. Understanding HSP 65 mechanisms can lead to innovative therapeutic approaches for managing cellular stress responses. Investigating HSP 65 expression patterns helps reveal its role in various physiological and pathological conditions. Current research highlights HSP 65's potential as a therapeutic target in multiple diseases. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of HSP 65's role in health and disease.